Author:
Knierer J.,Gallegos Morales E. N.,Schablon A.,Nienhaus A.,Kersten J. F.
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Safety Research,Toxicology
Reference35 articles.
1. U.S. Food and Drug Administration CfDaRH. QuantiFERON® -TB - P010033. Rockville; 2016. Approval letter. http://www.accessdata.fda.gov/cdrh_docs/pdf//p010033a.pdf . Accessed 16 Jun 2016.
2. Nienhaus A, Ringshausen FC, Costa JT, Schablon A, Tripodi D. IFN-gamma release assay versus tuberculin skin test for monitoring TB infection in healthcare workers. Expert Rev Anti Infect Ther. 2013;11:37–48.
3. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149:177–84.
4. Diel R, Loddenkemper R, Nienhaus A. Evidence-Based Comparison of Commercial Interferon-gamma Release Assays for Detecting Active TB. Chest. 2010;137:952–68.
5. Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori GB, Bossink A, Dheda K, Diel R, Dominguez J, et al. Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur RespirJ. 2011;37:100–11.
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献